- Any English- (NotEqual)or Spanish-speaking participant whose primary NIH Investigator is a CCGO PI, who has ordered a CLIA exome from NISC, or who has received a positive secondary variant result from the SGFS. Participants in a CSER protocol who have received a positive secondary finding through their CSER study are also eligible for enrollment in this protocol.